DMPK / Exploratory Toxicology

Service Pages

Questions?

ChemPartner’s Drug Metabolism Pharmacokinetic (DMPK) and Exploratory Toxicology department consists of in vitro ADME, pharmacokinetics (PK), non-GLP toxicology, and bioanalytical (GLP and non-GLP) function groups. Our leadership team, drawing on experience from world-renowned pharmaceutical companies, emphasizes a science-based culture and executes quality DMPK/toxicology studies as well as integrates DMPK/toxicology data into our biopharmaceutical clients’ discovery programs. DMPK/exploratory tox department also conducts studies for many pharmaceutical and biotech clients in support of their regulatory filings.

Since 2007, extensive ADME profiling (80,000+) and PK and exploratory toxicology studies (50,000+) have been conducted to support numerous drug discovery and development programs with our worldwide partners. Working closely with ChemPartner’s internal biology/pharmacology, and antibody engineering teams, our DMPK group supports translational medicine through our expertise in formulation development, in vitro-in vivo extrapolation, PK/PD modeling, biomarker analysis, and metabolomics. 

We take pride in our work and view our partners’ success as our success.

 

Our Services:

 

Headquarters

1F & 3F, Block A
2829 JinKe Road
Zhangjiang Hi-Tech Park
PuDong New Area
Shanghai China, 201203

w

Contact Us

China: +86 21 5132 0088
US: +1 650 419 9974
Europe: +45 4586 9000
Japan: +81 03 5403 6975

contact@chempartner.com